The reason(s) for this, however, are unclear at this time, although it might be speculated that cortical LBD are somehow protective with respect to AD-type neurodegeneration, or that qualitative, rather than quantitative, group pathology differences may be responsible, such as structural “strain” differences in α-synuclein, Aβ or tau aggregates. This evidence concerns the gene MAPT and Alzheimer disease.